National and Kapodistrian University of Athens
A method for parsing clinical outcomes and combining them with phosphoproteomic and genomic data for predicting drug efficacy: application in hepatocellular carcinoma
Abstract
dc:descriptionSystems biology has become an essential component of drug discovery, attempting to combine experimental data with computational modeling to capture different levels of cellular function (such as signaling, transcription, regulation) and integrate them in predictive models. These models are then used to best understand the drug mode of action (MOA), identify new targets and predict clinical drug efficacy and toxicity. In this study, we tried to identify signaling pathways related to drug efficacy in one of the most lethal malignancies worldwide, hepatocellular carcinoma (HCC). Particularly, gene expression data were collected for various HCC cell lines treated with anticancer compounds of known clinical efficacy. Each compound had been categorized with a ‘pass’ or ‘fail’ label according to their success or failure in human clinical trials. For labeling each drug we constructed a graphical user interface that parses clinical trials databases for clinical outcomes containing the respective compound. Thus, having available a dataset consisting of labeled drugs as observations and genes as features a supervised learning method was applied (feature selection) to identify genes predictive of the drugs’ clinical efficacy. Finally, using the extracted data as an input to a pathway construction algorithm, we were able to infer signaling networks on the proteomic level that best fit the measured gene expression signatures. We identified reactions and pathways playing an important role as accurate predictors for the efficacy of nine drugs in HCC.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Αηδονόπουλος Ορφέας
Rights
- Language dc:language
- English
Identifiers
dc:identifier.*- Identifier
- uoadl:1320816